Search All UT System Experts

Phase 1/2 dose escalating study of twice-monthly pemetrexed and gemcitabine in patients with advanced cancer and non-small cell lung cancer

Arkadiusz Z. Dudek, Timothy Larson, Michael J. McCleod, Daniel J. Schneider, Jonathan E. Dowell, Tarit K. Banerjee, Kishan J. Pandya, Jane L. Bromund, Ruqin Chen, Matthew J. Monberg, Coleman K. Obasaju

Research output: Contribution to journal › Article › peer-review

17 Scopus citations

Fingerprint

Dive into the research topics of 'Phase 1/2 dose escalating study of twice-monthly pemetrexed and gemcitabine in patients with advanced cancer and non-small cell lung cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences